N-Phenyl-2-p-tolylthiazole-4-carboxamide derivatives: Syn-thesis and cytotoxicity evaluation as anticancer agents

Abstract

<em>Objective(s)</em>:According to the prevalence of neoplastic diseases, there is a deep necessity for discovery of novel anticancer drugs in the field of medicinal chemistry. In the current study, a new series ofphenylthiazole derivatives(compounds 4a-4f) was synthesizedand theiranticancer activity was assessed <em>in vitro</em>. <em>Materials and Methods:</em>All synthesized derivatives were evaluated towards three human cancerous cell lines of SKNMC (Neuroblastoma), Hep-G2 (Human hepatocarcinoma) and MCF-7 cell (Breast cancer) using MTT assay and obtained values (IC₅₀ ± SD) were compared with doxorubicin. <em>Results:</em>Unfortunately, none of the synthesized compounds showed superior activity than doxorubicin against cancerous cell lines. MCF-7 cell line was the most resistant cell line against tested compounds. Compounds 4c with <em>para</em> nitro (IC₅₀ = 10.8 ± 0.08 µM) and 4d with <em>meta</em> chlorine (IC₅₀ = 11.6 ± 0.12 µM) moieties exerted thehighest cytotoxic effects towardsSKNMC and Hep-G2 cell lines respectively. <em>Conclusion: </em>A new series of phenylthiazole derivatives were synthesized and their anticancer activity was assessed against cancerous cell lines. More structural modifications and derivatization is necessary to achieve to the more potent compounds.